Methylphenidate-Induced Awake Bruxism: A Case Report

dc.contributor.authorSivri, Rukiye Colak
dc.contributor.authorBilgic, Ayhan
dc.date.accessioned2024-02-23T14:23:31Z
dc.date.available2024-02-23T14:23:31Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractMethylphenidate (MPH) is a stimulant that is commonly used in the treatment of attention-deficit/hyperactivity disorder in children and adults. Several reports are available regarding the relationship of MPH use and sleep bruxism. We report the case of a 9-year-old boy who presented with severe awake bruxism after his second dose of sustained release form of MPH treatment, which was confirmed on rechallenge. This is the first report of its kind showing such relationship in the literature.en_US
dc.identifier.doi10.1097/WNF.0000000000000068
dc.identifier.endpage61en_US
dc.identifier.issn0362-5664
dc.identifier.issn1537-162X
dc.identifier.issue2en_US
dc.identifier.pmid25768854en_US
dc.identifier.scopus2-s2.0-84925881798en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage60en_US
dc.identifier.urihttps://doi.org/10.1097/WNF.0000000000000068
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13594
dc.identifier.volume38en_US
dc.identifier.wosWOS:000351678500006en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofClinical Neuropharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMethylphenidateen_US
dc.subjectAwake Bruxismen_US
dc.subjectSide Effecten_US
dc.titleMethylphenidate-Induced Awake Bruxism: A Case Reporten_US
dc.typeReview Articleen_US

Dosyalar